CorMedix Inc’s recent filing unveils that its EVP, Chief Commercial Officer Mistry Erin acquired Company’s shares for reported $14985.0 on Oct 31 ’24. In the deal valued at $9.99 per share,1,500 shares were bought. As a result of this transaction, Mistry Erin now holds 52,011 shares worth roughly $0.54 million.
Then, Hurlburt Elizabeth sold 140,027 shares, generating $1,565,670 in total proceeds. Upon selling the shares at $11.18, the EVP now owns 45,397 shares.
Before that, Hurlburt Elizabeth bought 140,027 shares. CorMedix Inc shares valued at $1,556,416 were divested by the Officer at a price of $11.12 per share.
Rodman & Renshaw initiated its CorMedix Inc [CRMD] rating to a Buy in a research note published on August 26, 2024; the price target was $13. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early August with a ‘”an Outperform”‘ rating. Needham began covering CRMD with “Buy” recommendation on February 17, 2021. JMP Securities started covering the stock on September 29, 2020. It rated CRMD as “a Mkt outperform”.
Price Performance Review of CRMD
On Tuesday, CorMedix Inc [NASDAQ:CRMD] saw its stock jump 29.89% to $10.30. Over the last five days, the stock has gained 27.16%. CorMedix Inc shares have risen nearly 27.16% since the year began. Nevertheless, the stocks have risen 203.83% over the past one year. While a 52-week high of $13.85 was reached on 01/07/25, a 52-week low of $2.89 was recorded on 01/06/25. SMA at 50 days reached $9.83, while 200 days put it at $6.80.
Levels Of Support And Resistance For CRMD Stock
The 24-hour chart illustrates a support level at 9.48, which if violated will result in even more drops to 8.65. On the upside, there is a resistance level at 11.01. A further resistance level may holdings at 11.71. The Relative Strength Index (RSI) on the 14-day chart is 63.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.03%. Stochastics %K at 41.35% indicates the stock is a holding.
How much short interest is there in CorMedix Inc?
A steep rise in short interest was recorded in CorMedix Inc stocks on 2024-12-13, dropping by -0.11 million shares to a total of 6.73 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.84 million shares. There was a decline of -1.66%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 21, 2020 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
